Intracellular signaling pathways involved in inhibition of PAI-1 expression by CNP in endothelial cells

被引:3
作者
Jerczynska, H. [1 ]
Pawlowska, Z. [1 ]
机构
[1] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland
关键词
Natriuretic peptides; MEK/ERK; NF kappa B; PI3K/AKT; TNF alpha; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ATRIAL-NATRIURETIC-PEPTIDE; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; PROTEIN-KINASE ACTIVATION; VASCULAR SMOOTH-MUSCLE; FACTOR-ALPHA; TISSUE FACTOR; TYPE-1; EXPRESSION; NITRIC-OXIDE;
D O I
10.1016/j.regpep.2009.02.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PAI-1 is a multifunctional protein stimulated by infectious agents and its activation is mediated by inflammatory cytokines such as TNF alpha. Recent studies demonstrate that natriuretic peptides, particularly C-type (CNP), can affect PAI-1 expression in bovine aortic smooth muscle cells and rat aortic endothelial cells. We have previously shown that CNP inhibits both basal and TNF alpha induced expression of PAI-1 in human endothelial cells. Herein, we describe mechanism by which CNP modulates signaling engaged in controlling PAI-1 expression in human endothelial cells. To examine which pathway initiated by TNF alpha is influenced, we tested kinase activity of MAP, PI3K/AKT and involvement of cGMP in endothelial cells exposed to CNP. CNP significantly increased cGMP level in endothelial cells. Its analogue, 8-Br-cGMP alone had no effect but significantly inhibited TNF alpha induced expression of PAI-1. Similarly, CNP and the inhibitors of ERK1/2 (PD098059) and PI3K (LY294002) attenuated PAI-1 expression induced by TNF alpha. CNP almost abolished TNF alpha induced phosphorylation of ERK1/2 but did not affect JNK phosphorylation, indicating that its effect on ERK1/2 was specific. These data suggest that CNP might function as the natural defense of vascular wall against cytokine induced PAI-1 release through its ability to inactivate PI3K/AKT and MEK/ERK pathways. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 43 条
[1]   The natriuretic peptides - An introduction [J].
Baxter, GF .
BASIC RESEARCH IN CARDIOLOGY, 2004, 99 (02) :71-75
[2]   Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells - Role of cGMP in the regulation of the plasminogen system [J].
Bouchie, JL ;
Hansen, H ;
Feener, EP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1771-1779
[3]  
Chen HH, 1998, J CARDIOVASC PHARM, V32, pS22
[4]   Endothelial nuclear factor-κB translocation and vascular cell adhesion molecule-1 induction by complement inhibition with anti-human C5 therapy or cGMP analogues [J].
Collard, CD ;
Agah, A ;
Reenstra, W ;
Buras, J ;
Stahl, GL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (11) :2623-2629
[5]  
DAWSON SJ, 1993, J BIOL CHEM, V268, P10739
[6]   Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression -: A potential link to accelerated arteriosclerosis [J].
Dechend, R ;
Maass, M ;
Gieffers, J ;
Dietz, R ;
Scheidereit, C ;
Leutz, A ;
Gulba, DC .
CIRCULATION, 1999, 100 (13) :1369-1373
[7]   Conditional inhibition of the mitogen-activated protein Kinase cascade by wortmannin - Dependence of signal strength [J].
Duckworth, BC ;
Cantley, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27665-27670
[8]   Plasminogen activator inhibitor-1 and the kidney [J].
Eddy, AA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 283 (02) :F209-F220
[9]  
EMEIS JJ, 1988, BLOOD, V71, P1669
[10]   Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury [J].
Fay, WP .
TRENDS IN CARDIOVASCULAR MEDICINE, 2004, 14 (05) :196-202